Cargando…
Biomarkers characterization of circulating tumour cells in breast cancer patients
INTRODUCTION: Increasing evidence supports the view that the detection of circulating tumor cells (CTCs) predicts outcomes of nonmetastatic breast cancer patients. CTCs differ genetically from the primary tumor and may contribute to variations in prognosis and response to therapy. As we start to und...
Autores principales: | Nadal, Rosa, Fernandez, Ana, Sanchez-Rovira, Pedro, Salido, Marta, Rodríguez, María, García-Puche, José Luis, Macià, Marta, Corominas, Josep Maria, Delgado-Rodriguez, Miguel, Gonzalez, Lucas, Albanell, Joan, Fernández, Mónica, Solé, Francesc, Lorente, José Antonio, Serrano, María José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446333/ https://www.ncbi.nlm.nih.gov/pubmed/22554015 http://dx.doi.org/10.1186/bcr3180 |
Ejemplares similares
-
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014) -
A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs
por: Puche-Sanz, Ignacio, et al.
Publicado: (2017) -
FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors
por: Carracedo, Alma, et al.
Publicado: (2009) -
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry
por: Salido, Marta, et al.
Publicado: (2005) -
Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects
por: Moreno, María, et al.
Publicado: (2014)